Advertisement

Black-Spot Toxicodendron Dermatitis With Varied Presentation

      This article describes the clinical presentation, differential diagnosis, and treatment of 2 unrelated cases with different presentations of black-spot Toxicodendron dermatitis. In the first case, a healthy 7-y-old male presented with a rash consisting of black dots with localized surrounding erythema on the left arm. The rash then progressed to a vesicular, pinpoint, raised rash spreading to the face, arms, and neck. In the second case, a 4-y-old male presented with non-pruritic, black, flat, non-erythematous lesions that did not progress. This patient’s older sibling had been diagnosed with poison ivy 1 wk prior, and they attended the same child care where the poison ivy was thought to be acquired. In both cases, diagnosis of black-spot Toxicodendron dermatitis was made. The black spot of Toxicodendron dermatitis is caused by urushiol oxidation on exposure to air. The subject may or may not go on to develop allergic contact dermatitis after the exposure. Diagnosis of this dermatitis is made on clinical presentation, with careful consideration of history, distribution, and lesion morphology. When allergic dermatitis does develop as in the first case, systemic treatment with oral steroids is recommended. In both of these cases the black dots completely resolved in 2 to 3 wk. Dermatologic referral for dermoscopy and biopsy may be necessary if the dermatosis does not resolve as anticipated.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Wilderness & Environmental Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kim Y.
        • Flamm A.
        • ElSohly M.A.
        • Kaplan D.H.
        • Hage Jr., R.J.
        • Hamann C.P.
        • et al.
        Poison ivy, oak, and sumac dermatitis: what is known and what is new?.
        Dermatitis. 2019; 30: 183-190
        • Ziska L.H.
        • Sicher R.C.
        • George K.
        • Mohan J.E.
        Rising atmospheric carbon dioxide and potential impacts on the growth and toxicity of poison ivy (Toxicodendron radicans).
        Weed Sci. 2007; 55: 288-292
        • Murcia C.
        Edge effects in fragmented forests: implications for conservation.
        Trends Ecol Evol. 1995; 10: 58-62
        • Gladman A.C.
        Toxicodendron dermatitis: poison ivy, oak, and sumac.
        Wilderness Environ Med. 2006; 17: 120-128
        • Fisher A.A.
        • Mitchell J.C.
        Toxicodendron plants and spices.
        in: Riestchel R.L. Fisher’s Contact Dermatitis. 4th ed. Williams & Wilkins, Baltimore, MD1995: 461-523
        • Guin J.D.
        The black spot test for recognizing poison ivy and related species.
        J Am Acad Dermatol. 1980; 2: 332-333
        • Crosby D.F.
        The Poisoned Weed: Plants Toxic to the Skin.
        Oxford University Press, New York, NY2004
        • Freeman E.E.
        • Suchismita P.
        • Shofner J.D.
        • Kimball A.B.
        Plant-induced dermatitis.
        in: Auerbach P.S. Wilderness Medicine. 7th ed. Elsevier-Mosby, Philadelphia, PA2012: 1414-1433
        • McNair J.B.
        Rhus Dermatitis: From Rhus Toxicodendron, Radicans and Diversiloba (Poison Ivy) Its Pathology and Chemotherapy.
        University of Chicago Press, Chicago, IL1923
        • Paniagua C.T.
        • Bean A.S.
        Black-spot poison ivy: a rare phenomenon.
        J Am Assoc Nurse Pract. 2011; 23: 275-277
        • Kurlan J.G.
        • Lucky A.W.
        Black spot poison ivy: a report of 5 cases and a review of the literature.
        J Am Acad Dermatol. 2001; 45: 246-249
        • Chastant L.R.
        • Davis T.
        • Libow L.
        Black-spot poison ivy, a report of 3 cases with clinicopathologic correlation.
        JAAD Case Rep. 2018; 4: 140-142
        • Sivan K.
        • Robin P.G.
        Itchy black spots: poison ivy or something else?.
        Contemp Pediatr. 2020; 37: 32-33
        • Rader R.K.
        • Mu R.
        • Shi H.
        • Stoecker W.V.
        • Hinton K.A.
        Dermoscopy of black-spot poison ivy.
        Dermatology Online J. 2012; 18: 8
        • Mallory S.B.
        • Miller O.F.
        • Tyler W.B.
        Toxicodendron radicans dermatitis with black lacquer deposit on the skin.
        J Am Acad Dermatol. 1982; 6: 363-368
        • Williams J.V.
        • Light J.
        • Maks J.G.
        Individual variations in allergic contact dermatitis from urushiol.
        Arch Dermatol. 1999; 135: 1002-1003
        • Curtis G.
        • Lewis A.C.
        Treatment of severe poison ivy: a randomized, controlled trial of long versus short course oral prednisone.
        J Clin Med Res. 2014; 6: 429-434
        • Vernon H.J.
        • Olsen E.A.
        A controlled trial of clobetasol propionate ointment 0.05% in the treatment of experimentally induced Rhus dermatitis.
        J Am Acad Dermatol. 1990; 23: 829-832
        • Goodall J.
        Oral corticosteroids for poison ivy dermatitis.
        CMAJ. 2002; 166: 300-301
        • Moe J.F.
        How much steroid for poison ivy?.
        Postgrad Med. 1999; 106 (21, 24): 21-24
        • Crosby D.G.
        The Poisoned Weed: Plants Toxic to the Skin.
        Oxford University Press, New York, NY2004
        • Davila A.
        • Laurora M.
        • Fulton J.
        • Jacoby J.L.
        • Heller M.B.
        • Reed J.
        A new topical agent, Zanfel, ameliorates urushiol-induced toxicodendron allergic contact dermatitis.
        Ann Emerg Med. 2003; 42: S98